Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
RESEARCH TOOLSreports
Chemomab Therapeutics (CMMB) Stock Price & Analysis
189 Followers
CMMB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.42 - $1.39
Previous Close$1.16
Volume56.26K
Average Volume (3M)101.61K
Market Cap
$17.42M
Enterprise Value-$2.90M
Total Cash (Recent Filing)$19.78M
Total Debt (Recent Filing)$392.00K
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Aug 09, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.59
Shares Outstanding14,204,735
10 Day Avg. Volume95,869
30 Day Avg. Volume101,610
Standard Deviation0.23
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.78
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.12
Forecast
1Y Price Target
$5.67Price Target Upside362.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Chemomab Therapeutics News
Ownership Overview
28.05%
Insiders
0.08% Mutual Funds
17.27% Other Institutional Investors
54.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CMMB FAQ
What was Chemomab Therapeutics’s price range in the past 12 months?
Chemomab Therapeutics lowest stock price was $0.42 and its highest was $1.39 in the past 12 months.
What is Chemomab Therapeutics’s market cap?
Currently, no data Available
When is Chemomab Therapeutics’s upcoming earnings report date?
Chemomab Therapeutics’s upcoming earnings report date is Aug 09, 2024 which is in 17 days.
How were Chemomab Therapeutics’s earnings last quarter?
Chemomab Therapeutics released its earnings results on May 09, 2024. The company reported -$0.014 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.004.
Is Chemomab Therapeutics overvalued?
According to Wall Street analysts Chemomab Therapeutics’s price is currently Undervalued.
Does Chemomab Therapeutics pay dividends?
Chemomab Therapeutics does not currently pay dividends.
What is Chemomab Therapeutics’s EPS estimate?
Chemomab Therapeutics’s EPS estimate is -$0.1.
How many shares outstanding does Chemomab Therapeutics have?
Chemomab Therapeutics has 14,218,998 shares outstanding.
What happened to Chemomab Therapeutics’s price movement after its last earnings report?
Chemomab Therapeutics reported an EPS of -$0.014 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went up 12.5%.
Which hedge fund is a major shareholder of Chemomab Therapeutics?
Among the largest hedge funds holding Chemomab Therapeutics’s share is ARK Investment Management LLC. It holds Chemomab Therapeutics’s shares valued at N/A.
---
Chemomab Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.67 (362.86% Upside)
$5.67 (362.86% Upside)
Hedge Fund Trend
Decreased
By 792.0 Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.07%
12-Months-Change
Fundamentals
Return on Equity
-93.56%
Trailing 12-Months
Asset Growth
-48.56%
Trailing 12-Months
Company Description
Chemomab Therapeutics
Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.
---
CMMB Stock 12 Month Forecast
Average Price Target
$5.67
▲(362.86% Upside)
Technical Analysis
Best Analysts Covering CMMB
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-46.17%
reiterated a buy rating 2 months ago
Copying Jeff Jones's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -46.17% per trade.
---